Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury

Proinflammatory mediators trigger intensive postischemic inflammatory remodeling of the blood–brain barrier (BBB) including extensive brain endothelial cell surface and junctional complex changes. Junctional adhesion molecule-A (JAM-A) is a component of the brain endothelial junctional complex with...

Full description

Bibliographic Details
Main Authors: Nikola Sladojevic, Svetlana M. Stamatovic, Richard F. Keep, Jamison J. Grailer, J. Vidya Sarma, Peter A. Ward, Anuska V. Andjelkovic
Format: Article
Language:English
Published: Elsevier 2014-07-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996114000710
_version_ 1818675871809011712
author Nikola Sladojevic
Svetlana M. Stamatovic
Richard F. Keep
Jamison J. Grailer
J. Vidya Sarma
Peter A. Ward
Anuska V. Andjelkovic
author_facet Nikola Sladojevic
Svetlana M. Stamatovic
Richard F. Keep
Jamison J. Grailer
J. Vidya Sarma
Peter A. Ward
Anuska V. Andjelkovic
author_sort Nikola Sladojevic
collection DOAJ
description Proinflammatory mediators trigger intensive postischemic inflammatory remodeling of the blood–brain barrier (BBB) including extensive brain endothelial cell surface and junctional complex changes. Junctional adhesion molecule-A (JAM-A) is a component of the brain endothelial junctional complex with dual roles: paracellular route occlusion and regulating leukocyte docking and migration. The current study examined the contribution of JAM-A to the regulation of leukocyte (neutrophils and monocytes/macrophages) infiltration and the postischemic inflammatory response in brain ischemia/reperfusion (I/R injury). Brain I/R injury was induced by transient middle cerebral artery occlusion (MCAO) for 30 min in mice followed by reperfusion for 0–5 days, during which time JAM-A antagonist peptide (JAM-Ap) was administered. The peptide, which inhibits JAM-A/leukocyte interaction by blocking the interaction of the C2 domain of JAM-A with LFA on neutrophils and monocytes/macrophages, attenuated I/R-induced neutrophil and monocyte infiltration into brain parenchyma. Consequently, mice treated with JAM-A peptide during reperfusion had reduced expression (~3-fold) of inflammatory mediators in the ischemic penumbra, reduced infarct size (94 ± 39 vs 211 ± 38 mm3) and significantly improved neurological score. BBB hyperpermeability was also reduced. Collectively, these results indicate that JAM-A has a prominent role in regulating leukocyte infiltration after brain I/R injury and could be a new target in limiting post-ischemic inflammation.
first_indexed 2024-12-17T08:34:28Z
format Article
id doaj.art-be26f4c1339244e68041ab1d400ff618
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-17T08:34:28Z
publishDate 2014-07-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-be26f4c1339244e68041ab1d400ff6182022-12-21T21:56:31ZengElsevierNeurobiology of Disease1095-953X2014-07-01675770Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injuryNikola Sladojevic0Svetlana M. Stamatovic1Richard F. Keep2Jamison J. Grailer3J. Vidya Sarma4Peter A. Ward5Anuska V. Andjelkovic6Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USADepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USADepartment of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USADepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USADepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USADepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USADepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Corresponding author at: Departments of Pathology and Neurosurgery, University of Michigan, Medical School, 7520A MSRB I, 1150 W Medical Center Dr, Ann Arbor, MI 48109-5602, USA. Fax: +1 734 764 4308.Proinflammatory mediators trigger intensive postischemic inflammatory remodeling of the blood–brain barrier (BBB) including extensive brain endothelial cell surface and junctional complex changes. Junctional adhesion molecule-A (JAM-A) is a component of the brain endothelial junctional complex with dual roles: paracellular route occlusion and regulating leukocyte docking and migration. The current study examined the contribution of JAM-A to the regulation of leukocyte (neutrophils and monocytes/macrophages) infiltration and the postischemic inflammatory response in brain ischemia/reperfusion (I/R injury). Brain I/R injury was induced by transient middle cerebral artery occlusion (MCAO) for 30 min in mice followed by reperfusion for 0–5 days, during which time JAM-A antagonist peptide (JAM-Ap) was administered. The peptide, which inhibits JAM-A/leukocyte interaction by blocking the interaction of the C2 domain of JAM-A with LFA on neutrophils and monocytes/macrophages, attenuated I/R-induced neutrophil and monocyte infiltration into brain parenchyma. Consequently, mice treated with JAM-A peptide during reperfusion had reduced expression (~3-fold) of inflammatory mediators in the ischemic penumbra, reduced infarct size (94 ± 39 vs 211 ± 38 mm3) and significantly improved neurological score. BBB hyperpermeability was also reduced. Collectively, these results indicate that JAM-A has a prominent role in regulating leukocyte infiltration after brain I/R injury and could be a new target in limiting post-ischemic inflammation.http://www.sciencedirect.com/science/article/pii/S0969996114000710Tight junctionsJAM-AStrokeInflammationBlood–brain barrier
spellingShingle Nikola Sladojevic
Svetlana M. Stamatovic
Richard F. Keep
Jamison J. Grailer
J. Vidya Sarma
Peter A. Ward
Anuska V. Andjelkovic
Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury
Neurobiology of Disease
Tight junctions
JAM-A
Stroke
Inflammation
Blood–brain barrier
title Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury
title_full Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury
title_fullStr Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury
title_full_unstemmed Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury
title_short Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury
title_sort inhibition of junctional adhesion molecule a lfa interaction attenuates leukocyte trafficking and inflammation in brain ischemia reperfusion injury
topic Tight junctions
JAM-A
Stroke
Inflammation
Blood–brain barrier
url http://www.sciencedirect.com/science/article/pii/S0969996114000710
work_keys_str_mv AT nikolasladojevic inhibitionofjunctionaladhesionmoleculealfainteractionattenuatesleukocytetraffickingandinflammationinbrainischemiareperfusioninjury
AT svetlanamstamatovic inhibitionofjunctionaladhesionmoleculealfainteractionattenuatesleukocytetraffickingandinflammationinbrainischemiareperfusioninjury
AT richardfkeep inhibitionofjunctionaladhesionmoleculealfainteractionattenuatesleukocytetraffickingandinflammationinbrainischemiareperfusioninjury
AT jamisonjgrailer inhibitionofjunctionaladhesionmoleculealfainteractionattenuatesleukocytetraffickingandinflammationinbrainischemiareperfusioninjury
AT jvidyasarma inhibitionofjunctionaladhesionmoleculealfainteractionattenuatesleukocytetraffickingandinflammationinbrainischemiareperfusioninjury
AT peteraward inhibitionofjunctionaladhesionmoleculealfainteractionattenuatesleukocytetraffickingandinflammationinbrainischemiareperfusioninjury
AT anuskavandjelkovic inhibitionofjunctionaladhesionmoleculealfainteractionattenuatesleukocytetraffickingandinflammationinbrainischemiareperfusioninjury